Mechanism of staurosporine-induced apoptosis in murine hepatocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 282, Issue 5 45-5, 2002, Pages

  Feng, Guoping ^a   Kaplowitz, Neil ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Caspase; Necrosis; Tumor necrosis factor

Indexed keywords

CASPASE; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; I KAPPA B KINASE; NITRIC OXIDE SYNTHASE; STAUROSPORINE; SYNAPSIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; LEUKEMIA CELL LINE; LIVER CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0036087152     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00467.2001     Document Type: Article

References (36)

1. Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver
2. Regulation of NF-κB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Cζ in primary endothelial cells
3. Death receptors: Signaling and modulation
4. An essential role for NF-kB in preventing TNF-α induced cell death
5. Fluid shear stress activation of IκB kinase is integrin-dependent
6. Staurosporine-induced neuronal death: Multiple mechanisms and methodological implications
7. Inhibition of interleukin-1-stimulated NF-κB Rel/p 65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity
8. Death receptors in liver biology and pathobiology
9. Colchicine protects mice against the lethal effect induced anti-Fas antibody
10. Apoptotic pathways: The roads to ruin
11. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
12. NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α- and Fas-mediated apoptosis
13. Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC 6 cells
14. Mechanism of liver cell injury
15. Apoptosis: A basic biological phenomenon with wide-range implications in tissue kinetics
16. The mitochondrial death/life regulator in apoptosis and necrosis
17. Apoptosis induction by caspase-8 is amplified through the mitochodrial release of cytochrome c
18. Cytochrome c and dATP-dependent formation of APAF-1/casapse-9 complex initiates an apoptotic protease cascade
19. Induction of apoptotic program in cell-free extract: Requirement for dATP and cytochrome c
20. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways
21. Apoptosis by death factor
22. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition
23. Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance of the cytochrome c-mediated caspase-9 death pathway
24. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
25. Staurosporine, K-252 and UCN-01: Potent but nonspecific inhibitors of protein kinases
26. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis
27. Apoptosis in the pathogenesis and treatment of disease
28. Suppression of TNF-α-induced apoptosis by NF-kB
29. The molecular biology of apoptosis
30. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-kB
31. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
32. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
33. Apoptosis (the 1992 Frank Rose Memorial Lecture)
34. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
35. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism
36. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300